AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 286 filers reported holding AVANOS MED INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $312 | -21.0% | 15,456 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $395 | -9.2% | 15,456 | +5.6% | 0.00% | 0.0% |
Q1 2023 | $435 | +9.8% | 14,640 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $396 | -99.9% | 14,640 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $319,000 | -31.0% | 14,640 | +6.1% | 0.00% | -20.0% |
Q1 2022 | $462,000 | -3.3% | 13,800 | 0.0% | 0.01% | +25.0% |
Q4 2021 | $478,000 | +10.9% | 13,800 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $431,000 | -6.9% | 13,800 | +8.4% | 0.00% | 0.0% |
Q2 2021 | $463,000 | +39.9% | 12,728 | +68.0% | 0.00% | +33.3% |
Q1 2021 | $331,000 | -4.9% | 7,575 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $348,000 | +128.9% | 7,575 | +65.6% | 0.00% | +50.0% |
Q3 2020 | $152,000 | +13.4% | 4,575 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $134,000 | +8.9% | 4,575 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $123,000 | -47.0% | 4,575 | -33.5% | 0.00% | -33.3% |
Q4 2019 | $232,000 | -10.1% | 6,875 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $258,000 | -14.0% | 6,875 | 0.0% | 0.00% | -25.0% |
Q2 2019 | $300,000 | -8.5% | 6,875 | -10.4% | 0.00% | 0.0% |
Q1 2019 | $328,000 | -4.7% | 7,675 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $344,000 | -34.6% | 7,675 | 0.0% | 0.01% | -16.7% |
Q3 2018 | $526,000 | – | 7,675 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |